Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:
May 11: VOA | US Plans to Accuse China of Hacking COVID-19 Vaccine Research
Given China's decades-long history of intellectual property theft, the notion that Beijing might be trying to steal research related to coronavirus vaccines and treatments is not far-fetched, Demers said.
May 15: Remarks by President Trump on Vaccine Development

archived
Jan 5-7: sars-cov-2 genome isolated, CN; Cell, Nature
Jan. 12: China adds sequence to US GenBank®
Jan 13-17: Diagnostic detection of 2019-nCoV by real-time RT-PCR, DE
Jan 30: characterisation and epidemiology, CN; Lancet
Feb 6: Experts scramble, Moderna
Mar 2: Coronavirus funding, Moderna
Mar 9: H.R.6074, purchase order
Mar 11:
O'Brien, 2 mo. missing "Made in China"
NIAID-Moderna, 14 mo trial begins
Mar 7-14: CureVac, China vaccines, Apr trials
"Moderna shipped its vaccine last month"
Mar 20: NIAID-Moderna-Kaiser vaccine, mRNA-1273
May 15: Trump names team to develop coronavirus vaccine
by Cat on Mon May 18th, 2020 at 05:31:11 AM EST
Fauci reads notes on Phase I [?!] trial. Moderna stock up 25% in early trading.
by Cat on Mon May 18th, 2020 at 08:46:52 PM EST
[ Parent ]
Early data on Moderna's COVID-19 vaccine insufficient: Stat News
The news publication's report pulled down shares of the Cambridge, Massachusetts-based biotech and erased modest gains on the benchmark S&P 500 index. ...Moderna later announced a stock sale that could raise about $1.5 billion, sending shares lower early on Tuesday.
by Cat on Wed May 20th, 2020 at 01:37:37 AM EST
[ Parent ]
by Cat on Wed May 27th, 2020 at 10:01:52 PM EST
[ Parent ]
Inovio says COVID-19 vaccine produces antibodies in mice, guinea pigs
The company's shares, which have more than quadrupled this year on hopes of its vaccine working, SURGED another 18% to $15.77 early trading.
[...]
Inovio began human testing of its vaccine in April. ... Inovio said preliminary results from its human trial are expected in June. The 40 healthy participants in the Phase 1 trial are given two shots, four weeks apart, of the vaccine, called INO-4800, and then followed for two weeks.
archived Fri Feb 7th, 2020

Diversity is the key to economic and political evolution.
by Cat on Thu May 21st, 2020 at 11:04:49 AM EST
[ Parent ]
dispensing with clinical pretext

Diversity is the key to economic and political evolution.
by Cat on Thu May 21st, 2020 at 03:21:18 PM EST
[ Parent ]

U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine, "previously known as ChAdOx1 nCoV-19 and now as AZD1222"
The U.S. deal allows a late-stage - Phase III - clinical trial of the vaccine with 30,000 people in the United States.


Diversity is the key to economic and political evolution.
by Cat on Thu May 21st, 2020 at 03:28:12 PM EST
[ Parent ]
Gilead to end coronavirus drug trials, adding to access worry: researchers, 15 May
Gilead's studies - one in patients with severe COVID-19 and the other in moderate disease - have enrolled around 8,000 [!] subjects, according to FDA statistics. The trials are "open label" meaning they do not compare the treatment to a placebo and participants know they are getting the drug.
wut: ClinicalTrial.gov | Adaptive COVID-19 Treatment Trial (ACTT), PHASE III 572(e)-800, 21 Feb 2020-Apr 2023
wut: ClinicalTrial.gov | A Trial of Remdesivir in Adults With Severe COVID-19, PHASE III 237, 6 Feb-15 Apr 2020 terminated
The NIH is now studying remdesivir alone compared to remdesivir in combination [?] with Olumiant, an anti-inflammatory [!] drug approved for rheumatoid arthritis and sold by Eli Lilly and Co.
[...]
Gilead told Tufts it is transitioning to product distribution under the emergency use authorization.

Researchers at Boston's Beth Israel Deaconess Medical Center have also heard that the two Gilead studies would stop enrolling patients by the end of the month.
[...]
After doctors had questioned the transparency of the allocation process, the federal agency [HHS] said state health departments would distribute the drug.

by Cat on Mon May 18th, 2020 at 09:18:35 PM EST
[ Parent ]
by Cat on Mon May 18th, 2020 at 11:02:30 PM EST
[ Parent ]
Woman [!] who designed Florida's COVID-19 dashboard has been REMOVED from her position
Rebekah Jones said in an email to CBS12 News that her removal was "not voluntary" and that she was removed from her position because she was ordered to censor some data, but refused to "MANually change data to drum up support for the plan to reopen."

Jones made the announcement May 5 in a farewell email to researchers and other members of the public who had signed up to receive updates on the data portal, according to Florida Today. She said that for "reasons beyond my division's control," her office is no longer managing the dashboard, involved in its publication, fixing errors or answering any questions.

unprecedented. egregious. inconceivable. unexpectedly.
by Cat on Tue May 19th, 2020 at 01:58:21 PM EST
[ Parent ]

Display:

Occasional Series